Eisaku Ogawa

1.8k citations
31 papers · 1.3k indexed · 1 hit paper · h-index 16
Topics
Psoriasis: Treatment and Pathogenesis (7 papers)Cancer-related Molecular Pathways (4 papers)Dermatology and Skin Diseases (4 papers)

In The Last Decade

Eisaku Ogawa

30 papers receiving 1.2k citations

Hit Papers

Pathogenesis of psoriasis and development of treatment20172026202020232017100200300

Peers

Eisaku Ogawa
Comparison fields: 5 of 96
  • Molecular Biology 501
  • Immunology 479
  • Dermatology 415
  • Oncology 186
  • Physiology 130
Replace Hongwei Han with:
Hongwei Han China
Thomas Rosenbach Germany
Hyosun Jang South Korea
Meimei Yin United States
Laure Favot France
Ana Silva Portugal
Anja Thielitz Germany
Ashley J. Fowler United States
Michitaka Shichijo Japan
Xiaohong Yang China
Eisaku Ogawa relative to Hongwei Han China Hongwei Han's profile →
Citations per field
00.5×1.5×
Hongwei Han · 1×
Citations per year

Countries citing papers authored by Eisaku Ogawa

Since Specialization
Citations

This map shows the geographic impact of Eisaku Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisaku Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisaku Ogawa more than expected).

Fields of papers citing papers by Eisaku Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eisaku Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisaku Ogawa. The network helps show where Eisaku Ogawa may publish in the future.

Co-authorship network of co-authors of Eisaku Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eisaku Ogawa. A scholar is included among the top collaborators of Eisaku Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eisaku Ogawa. Eisaku Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 10
4 214
5 2
6 15
7 1
8 27
9 1
10 26
11 1
12 77
13 3
14 2
15 32
16 19
17 45
18 61
19 21
20 160

About Eisaku Ogawa

Eisaku Ogawa is a scholar working on Dermatology, Immunology and Rheumatology, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (7 papers), Cancer-related Molecular Pathways (4 papers) and Dermatology and Skin Diseases (4 papers). The work is most often cited by research in Dermatology (415 citations), Immunology (479 citations) and Immunology and Allergy (114 citations). Eisaku Ogawa has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Ryuhei Okuyama, Yuki Sato, Akane Minagawa, Setsuya Aiba, Hachiro Tagami, Shuntaro Ikawa, Taku Fujimura, Ryo Funayama, Takeshi Nagashima and Eri Kobayashi. Their work appears in journals such as Journal of Biological Chemistry, Nature Immunology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026